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Abstract 1 
Biomonitoring has become the ‘gold standard’ in assessing chemical exposures, and plays an 2 
important role in risk assessment. The pooling of biological specimens – combining multiple 3 
individual specimens into a single sample – can be used in biomonitoring studies to monitor 4 
levels of exposure and identify exposure trends, or to identify susceptible populations in a 5 
cost-effective manner. Pooled samples provide an estimate of central tendency, and may also 6 
reveal information about variation within the population. The development of a pooling 7 
strategy requires careful consideration of the type and number of samples collected, the 8 
number of pools required, and the number of specimens to combine per pool in order to 9 
maximize the type and robustness of the data. Creative pooling strategies can be used to 10 
explore exposure-outcome associations, and extrapolation from other larger studies can be 11 
useful in identifying elevated exposures in specific individuals. The use of pooled specimens 12 
is advantageous as it saves significantly on analytical costs, may reduce the time and 13 
resources required for recruitment, and in certain circumstances, allows quantification of 14 
samples approaching the limit of detection. In addition, use of pooled samples can provide 15 
population estimates while avoiding ethical difficulties that may be associated with reporting 16 
individual results.  17 
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Introduction 18 
Exposure assessment is an essential component of chemical risk assessment, and regulatory 19 
and legislative bodies require exposure data to assess risks and to design and implement 20 
intervention strategies. Traditionally, indirect methods such as ambient environmental 21 
monitoring or self-administered questionnaires were used for the assessment and estimation 22 
of chemical exposures [1]. However, with the rapid advancement of sensitive analytical 23 
techniques, biomonitoring has become the ‘gold standard’ for the characterization of 24 
chemical exposure [2, 3]. Biomonitoring provides a direct measure of aggregate exposures at 25 
the time of sampling, rather than being limited to exposure estimates based on multiple 26 
measurements in multiple compartments (such as food, dust and air) that may have 27 
contributed to that exposure. For the purposes of this paper ‘biomonitoring’ refers 28 
specifically to chemical biomonitoring, and is defined as the systematic collection of human 29 
tissues and fluids such as blood, urine, hair or milk for the analysis of chemical contaminants 30 
and their metabolites and transformation products, to facilitate exposure assessment [4]. 31 
Further, ‘pooling’ refers to combining multiple individual specimens into a single sample 32 
using a set of grouping criteria e.g. age, sex etc. The focus of this review is the use of pooled 33 
samples for chemical biomonitoring, however many of the principles described below can 34 
also be applied to the analysis of biomarkers of exposure and biomarkers of effect such as 35 
clinical chemistry measures and DNA adducts.  36 
 37 
Over the last decade, the National Research Centre for Environmental Toxicology (Entox) at 38 
the University of Queensland in Australia has coordinated numerous biomonitoring studies of 39 
the general Australian population for selected persistent organic pollutants (POPs). Human 40 
biological specimens including blood, urine and breast milk have been collected and archived 41 
by Entox for the National environmental specimen bank. The majority of these biomonitoring 42 
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studies have used pooled samples obtained by combining de-identified, surplus pathology 43 
specimens. Pathology samples are readily available in Australia and likely also in other 44 
countries, and represent a potentially valuable resource for chemical biomonitoring.  45 
 46 
In traditional epidemiological settings emphasis has been placed on the importance of 47 
collecting and analysing individual specimens for biomonitoring. This sampling strategy 48 
represents a hyper-conservative approach that preserves the ability to relate individual 49 
outcomes to individual exposures, but this may not always be the optimal choice for all 50 
biomonitoring studies. For example, individual specimens are collected, analysed and 51 
archived for the German Environmental Survey and the German Environmental Specimen 52 
Bank [5]; however, much of the overall interpretation of the data is based on a quasi-pooled 53 
or -stratified results, such as investigations of trends in mean body burden for a particular 54 
chemical. For example, the reported decrease in urinary phthalate metabolite concentrations 55 
in young adults in Germany occurring contemporaneously with decreasing industrial 56 
production/consumption of the precursor compound [5]. The same temporal trend could have 57 
been observed and the same conclusion reached at a considerably reduced cost if a pooled 58 
sampling strategy had been employed.  59 
 60 
The use of pooled samples for biomonitoring is gradually becoming more popular. The 61 
World Health Organisation has coordinated four global studies, including the Global 62 
Monitoring Plan initiated in 2007, to monitor a range of POPs in ‘core media’ including 63 
pooled breast milk [6-9]. This pooled sampling approach is an efficient method for 64 
identifying trends in POPs exposures, and has been employed as a strategy to satisfy Articles 65 
11 and 16 of the Stockholm Convention by identifying priority POPs in the population and 66 
monitoring the levels of these POPs over time [7]. The first regional monitoring report for the 67 
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‘Western Europe and Other States’ group reports values of POPs for 2003 (± 5 years) in 28 68 
nations in Western Europe, North America and Australasia. For example, the toxic 69 
equivalency of PCDDs/PCDFs in breast milk in Belgium has declined from a range of 33.7-70 
40.2 pg/g lipid in 1987/88 to a mean value of 10.3pg/g lipid in 2007 [10]. This study provides 71 
evidence for the successful use of pooled samples to assess human exposures to POPs in 72 
several countries worldwide. 73 
 74 
This review critically reviews the potential uses of, approaches to, and limitations of pooled 75 
samples for biomonitoring of environmental chemicals in contrast to study designs using 76 
individual specimens. We explore the rationale for undertaking biomonitoring studies, and 77 
assess the effectiveness of pooled samples for meeting different study aims. Further, we 78 
discuss a range of potentially new approaches to developing pooling strategies, and creative 79 
applications of these pooled samples, with the aim of identifying opportunities to expand the 80 
usefulness of pooled samples in the areas of human biomonitoring and epidemiological 81 
research.  82 
 83 
Statistical Considerations 84 
The design of pooled sampling efforts for the characterization of biomarker concentrations in 85 
a population should be guided by the purpose and goals of the study [11-13]. According to 86 
the biological averaging assumption [14], the measured concentration in a pooled specimen is 87 
comparable to the arithmetic mean of concentration of individual specimens making up the 88 
pool. Thus, pool-based analyses provide a tool for estimating the central tendency (i.e. 89 
arithmetic mean) of a population or subpopulation, which in turn is useful for the assessment 90 
of relative exposure levels among subpopulations or for monitoring trends in levels over time 91 
or space.  92 
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   93 
For many applications, estimation of the central tendency and variation within a population or 94 
subpopulation is of interest. One such example is the identification of upper and lower 95 
percentiles of concentrations in the general population for use as reference values to define 96 
the ‘typical’ range of biomarker concentrations. Such reference values can be used in the 97 
evaluation of data from persons who may have experienced unusually high exposures in 98 
order to assess whether their exposure exceeds the range of exposures in the general 99 
population [15]. Data generated from pooled samples cannot be used to calculate the 100 
geometric mean or median of a population, and alone it cannot describe the population 101 
variance (Table 1).  102 
 103 
Under some conditions however, pooling approaches can be used to estimate variability of 104 
exposures in a population. For example, if the biomarker concentration is normally 105 
distributed in the population, then measured concentrations in multiple pooled samples drawn 106 
from that population will also be normally distributed with the same mean. Under ideal 107 
conditions, and with simple assumptions about the normality of the underlying population 108 
distribution, the population variance can be estimated based on the variance in the measured 109 
concentrations in multiple independently-constituted pools [11]. However, the application of 110 
this ideal concept is hampered by three factors: (1) the contribution of measurement error to 111 
variation in pooled sample measurements; (2) the contribution of pooling error to variation in 112 
pooled sample measurements; and (3) the shape of the underlying population distributions of 113 
chemical biomarker concentrations, which are rarely, if ever, normal distributions.  114 
 115 
In the context of analysis of trace levels of environmental chemicals in biological matrices, 116 
measurement error may be important when estimating population variation based on variation 117 
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in measurements of multiple pools. For example, for the quantification of mercury levels in 118 
whole blood, measurement error may be considered negligible (RSD <3%, n=815) [16], but 119 
for the analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in serum, the coefficient of 120 
variation is greater (%RSD <16%, n=20) [17], and measurement error may be significant. 121 
The extra handling and processing needed to physically pool samples can introduce a 122 
separate and independent source of error to the analysis, which Schisterman et al [12, 13] 123 
termed ‘pooling error’. Pooling error may be particularly relevant for pooled samples 124 
consisting of a large number of individual specimens, wherein the error is additive.  125 
 126 
Pooling error is principally related to the physical error associated with extracting and 127 
transferring precise volumes from multiple individual samples into the physical pool. Errors 128 
associated with these procedures can be amplified if the pooling procedure relies upon a 129 
weighting scheme. For example, Caudill [18] has proposed a pooling scheme in which the 130 
volume of sample from each individual included in the pool is proportional to the population 131 
statistical sample weight assigned to that individual in the complex survey design. In such a 132 
case, random error in the physical process of pooling may be magnified or distorted in that 133 
error in extracting or compositing samples from highly weighted individuals will impact the 134 
overall pool error to a greater extent. Quantifying and characterising this source of error may 135 
require physical experimentation, where the pooling process is replicated on stock solutions 136 
in order to evaluate the relative magnitude of this source of error compared to other potential 137 
sources, such as measurement error. 138 
 139 
Caudill [11, 18] has outlined statistical approaches to estimate population variance and 140 
specific percentiles based on the analysis of pooled samples for United States’ (US) National 141 
Health and Nutrition Examination Survey (NHANES) data. The approach relies upon (1) 142 
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assumption of log-normality in the underlying data; (2) the analysis of multiple pools to allow 143 
estimation of population variance; and (3) repeated analytical determinations of each pool to 144 
allow for estimation of variance from measurement error.  Based on observed variation in the 145 
pool measurements and the estimation of measurement error, the variance of the underlying 146 
population can be estimated [18]. The confidence in the estimate of underlying population 147 
variance increases with increasing numbers of pools from a given population strata. 148 
Similarly, the accuracy of the estimate of measurement error increases with increasing 149 
numbers of repeated analytical determinations per pool. These estimates of across-pool and 150 
within-pool variance can be combined with the weighted arithmetic mean of the measured 151 
pool concentrations to estimate both the geometric mean and specified percentiles in the 152 
population, again, under the assumption of log-normality for the population distribution. 153 
However, to the extent that the underlying population distribution departs from log normality, 154 
these approaches will not provide accurate estimations of population variance or distribution. 155 
 156 
Pooling versus random sampling strategies 157 
Recruitment 158 
One of the difficulties in assessing environmental exposures, particularly in population-wide 159 
studies, is the labour and resource-intensive nature of sampling and analysis of a large 160 
number of samples, especially for infants and young children. Inherent in such studies is the 161 
bias introduced through sampling design and participant selection (Table 1). When the aim of 162 
the study is to survey the ‘general population’, selection bias must be a real concern. There is 163 
consistent evidence that women and persons with higher socioeconomic status are more 164 
likely to participate in scientific studies [19], especially when the study burden is onerous. 165 
Numerous studies focus on associations between environmental exposure and socioeconomic 166 
status or ethnicity [20-23] and selection bias can result in invalid conclusions if this bias has 167 
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not been adequately addressed in the sampling design. A study that involves the collection of 168 
de-identified samples with equal representation of ethnic and socioeconomic groups may be 169 
more acceptable and help reduce this selection bias.  170 
 171 
Individual specimens collected as part of a study and pooled post hoc can be advantageous in 172 
that specimens collected during the course of an unrelated study can be exploited to answer 173 
research questions beyond the scope of the original study without requiring additional 174 
recruitment which might be prone to bias, as discussed above. For example, biological 175 
specimens collected during a cohort study investigating fluoride status can be used to monitor 176 
exposure to unrelated environmental chemicals.  177 
 178 
A largely untapped resource is specimens collected during the course of routine pathology 179 
testing, which can similarly be used to explore trends in certain subsets of the population. For 180 
example, in a study conducted at Entox by Toms et al [24] de-identified, surplus serum 181 
samples (n=2420) collected as part of routine pathology testing were stratified by age and 182 
sex, pooled (n=84), and analysed to investigate the association between concentration of 183 
polybrominated diphenyl ethers and age. The authors found that serum concentration peaked 184 
at 2.6-3 years (51±36ng/g lipid), after the typical cessation of breastfeeding, and concluded 185 
that young children have an additional exposure source for these chemicals.  186 
 187 
However, the use of pathology samples introduces potential bias into the study population, as 188 
the individuals providing the sample may not be truly representative of the normal population 189 
and may have some disturbance or perturbation of normal physiology. In order to assess this 190 
potential bias, a component of the Australian National Dioxins Program [25] investigated the 191 
levels of dioxins and dioxin-like chemicals in pathology samples (i.e. potentially ‘sick’ 192 
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individuals) compared to samples collected for insurance assessments (i.e. ‘healthy’ 193 
individuals) to determine if there were detectable differences between the two groups. For the 194 
majority of compounds the normalised difference between the two groups was <20% which 195 
may be explained by variations in analytical reproducibility, and the authors concluded that it 196 
was unlikely that sampling bias would result from the use of pathology samples.  197 
 198 
Financial Cost 199 
In most circumstances the single most motivating factor for using pooled samples in a study 200 
design is the significant expense associated with the analytical component of chemical 201 
analysis. Analytical methods with suitably sensitive limits of detection, such as high 202 
resolution or tandem mass spectrometry, are expensive and thus not readily accessible to a 203 
large number of laboratories. Furthermore, the logistics of collecting, storing and analysing 204 
samples becomes more complicated as the number of samples increases, such as when 205 
individual specimens are used in a random sampling design. The most obvious solution to 206 
this problem is to analyse fewer samples. Pooling allows a large number of samples to be 207 
systematically sorted and combined in such a way as to investigate particular elements of a 208 
population or study design while performing fewer analyses. Where the study aims can be 209 
achieved using pooled samples, hundreds of individual specimens can be combined to form a 210 
single pool, providing a cost effective study design through significantly reduced analytical 211 
costs [26]. This of course does not negate the time and resources required to collect, store and 212 
pool the individual specimens.  213 
 214 
Using a pooling strategy involves a trade-off between the cost of analysis and the amount of 215 
information that can be gleaned from the data (Table 1). As discussed above, analysis of a 216 
pooled sample in which each individual specimen making up the pool is present in equal 217 
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volume provides an estimate of the arithmetic mean of the underlying population (see 218 
Statistical Considerations). If the underlying population data are highly skewed, an arithmetic 219 
mean estimate may be of limited use. Furthermore, estimating population variance requires 220 
analysis of multiple pools from the population [11, 18], and the confidence in both the 221 
estimate of the arithmetic mean and in the estimate of population variance is limited unless 222 
many pools are generated and analysed. Given that the analytical component of analysis is 223 
usually the most expensive, pooling can be a useful strategy where budget constraints exist, 224 
as long as the limitations in the resulting measurements are understood and conveyed.  225 
 226 
Analytical results subject to a limit of detection 227 
As with any biomonitoring study, there is the question of how to approach analytical results 228 
that are less than the limit of detection (LOD). A significant benefit of using a pooled sample 229 
design is that when the specimen volume is limited, pooling many specimens may allow 230 
achievement of a lower method LOD than available with individual specimens (Table 1), 231 
where an increased total sample volume can facilitate a larger concentration factor during 232 
extraction. As a result, a more accurate estimation of mean concentration for a population 233 
group may be available via the pooling approach than from analysis of individual specimens 234 
[11]. For example, the Canadian Health Measures Study utilises a stratified, weighted random 235 
sampling procedure to collect biological samples representative of the Canadian population 236 
[27]. In the initial stages of the study 2.7mL serum samples were used to measure the 237 
concentration of a range of POPs in the general population. However, the levels of POPs in 238 
these samples were frequently below the LOD, limiting the usefulness of the data for 239 
establishing national averages [27]. In a follow up study, Rawn et al [28] used a pooling 240 
strategy to estimate baseline concentrations of polychlorinated dibenzodioxins/furans and 241 
polychlorinated biphenyls for the same population. Leftover serum samples with a typical 242 
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sample volume of 350µL were pooled, where 80 individuals contributed to a single pool, to 243 
ensure sufficient sample volume (~25mL) was available for analysis and to reduce the 244 
number of undetected compounds. The pooling strategy allowed for an estimation of national 245 
averages for these chemicals where the analysis of individual specimens had proved 246 
inadequate.  247 
 248 
Another scenario where pooled samples are useful is when specimens are precious and/or 249 
highly coveted, such as with competing research interests. This is particularly the case for 250 
specimens from infants and young children, where sample collection is difficult e.g. urine 251 
from non-toilet-trained children; or where volume is strictly limited e.g. venous blood from 252 
neonates. For example, in the fourth German Environmental Survey pilot study of pesticide 253 
exposures in children, not all the specimens collected could be analysed, with 550 children 254 
recruited and only 360-400 specimens available for analysis, because the volume of urine 255 
available was too small, and the collection procedures were inadequate, particularly for 256 
children 0-2 years [29]. In this situation, a pooling strategy would have facilitated the creation 257 
of larger sample volumes allowing for further sample enrichment and consequently a 258 
concentration above the LOD.  259 
 260 
Schisterman and Vexter [12] propose a unique ‘pooled-unpooled resampling design’ to 261 
quantitate samples that may be <LOD, when cost and sample volume are not prohibitive. In 262 
this approach individual specimens are first analysed individually, then composited into pools 263 
and reanalysed as pooled samples. For the specimen that was <LOD when analysed 264 
individually, a concentration can be back-calculated using the pooled sample results and the 265 
individual results from the other specimens making up the pool. However, this is a resource-266 
intensive approach. As a general guide, Schisterman and Vexter suggest that where the mean 267 
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is <LOD [12, 13] or when 50% of the data are <LOD [30, 31], random sampling is more 268 
efficient than pooling for an accurate estimation of mean and variance.  269 
 270 
Formulating a pooling strategy 271 
Pooling specimens for biomonitoring can be particularly efficient and advantageous in 272 
targeted studies that have a clear goal or hypothesis that is being tested. A key consideration 273 
in formulating a pooling strategy is the question of how many individual specimens to 274 
include in each pooled sample. When using de-identified specimens there is a need to balance 275 
having a sufficient number of specimens in a pool to preserve individual anonymity with 276 
having an optimal number of pools in each stratum to adequately describe the variance. 277 
Collecting replicate samples (two or more pooled samples with the same pooling criteria, so 278 
that each strata has a minimum of two data points) and performing duplicate analyses can 279 
provide some estimate of measurement and pooling errors in addition to standard analytical 280 
quality control procedures. The more replicate samples available per strata, the more 281 
information on variance within that stratum that can be gained.  282 
 283 
Bignert [32] used generic computer-generated data to simulate random sampling from 284 
normally and log-normally distributed populations to investigate the relationships and trade-285 
offs between the number of individuals per pool, number of pools, variance and cost of 286 
analysis using pooled and individual samples. This illustrative study demonstrated that if 287 
analytical costs remain constant when the number of individual specimens per pool is 288 
increased, a larger number of individuals per pool provides a more accurate estimate of the 289 
true mean with the smallest variance. The variance can be reduced further by analysing more 290 
pools but this increases analytical costs. From Bignert’s data, the variance between sampling 291 
periods decreased from 20 to 14% when the number of individual samples was increased 292 
Page 14 of 34 
 
from 6 to 12. The same variance was achieved using 2 pooled samples, where each pool 293 
contained 6 individual specimens, and analytical costs were reduced by 80%. If more pooled 294 
samples were used (n=5) the variance was reduced to 10%, but analytical costs increased 295 
accordingly. Alternatively, if the pool size was increased to contain 12 individual specimens, 296 
the variance was reduced to 12% using 2 pooled samples, or 8% using 5 pooled samples.  297 
 298 
When developing a pooling strategy the approach to data normalisation should also be 299 
considered. Under ideal circumstances, researchers would have access to parameters for data 300 
normalisation (e.g. lipid content, creatinine, or specific gravity measures) of each individual 301 
specimen prior to pooling. If the pool mean is to be normalised, for example reporting a 302 
chemical concentration as x ng/g lipid, then the specimens should be pooled such that each 303 
individual contributes an equal amount of lipid, but potentially a different volume to the 304 
sample pool. Of course data on lipid content and other similar parametric data is not always 305 
available prior to pooling. If no data normalisation is to be performed, or cannot be 306 
performed due to lack of data, the specimens may be pooled by volume, where each 307 
individual specimen contributes the same volume to the pool. Under these conditions the 308 
biological averaging assumption holds true only for volumetric concentrations.  309 
 310 
Ultimately the optimal pooling strategy is a function of the aims of the study, the potential 311 
outcomes, analytical requirements (LODs, minimum sample volume etc.) and budget 312 
constraints; and will be unique for each study.  313 
 314 
Reporting results 315 
As stated by the US National Research Council [3], the ability to generate biomonitoring data 316 
has well out-paced our ability to interpret such data in the context of public health, and the 317 
Page 15 of 34 
 
ethical and scientific challenges of reporting results in human biomonitoring studies are well 318 
documented [33-36]. The difficulty arises because only a small percentage of the compounds 319 
measured routinely have been studied in enough detail to elucidate relationships between 320 
exposure, metabolism and toxicity e.g. some pesticides (e.g. chlorpyrifos), metals (e.g. lead) 321 
and volatile compounds (e.g. benzene) (Figure 1). For most compounds there is a lack of 322 
toxicological or pharmacokinetic data for modelling, and/or a lack of epidemiological 323 
evidence regarding potential health effects, particularly for chronic low dose exposures [33, 324 
34]. This means that there is no clear relationship between the chemical or biomarker 325 
concentration and toxicity or other health endpoint; limiting the benefit to an individual from 326 
knowing their biomarker concentration. It is also uncommon that a physician or health care 327 
professional can link that concentration to a particular disease and then recommend treatment 328 
[34]. Recent efforts have been made to apply available data on pharmacokinetics in order to 329 
translate existing chemical-specific risk assessment-based exposure guidance values to 330 
corresponding chemical concentrations (parent or metabolite) in blood or urine [15, 37]. This 331 
has expanded the number of analytes that can be evaluated in the context of current risk 332 
assessments on a population basis; however, these screening values do not provide diagnostic 333 
information or improve the utility of biomarker measurements for individual health risk 334 
assessment.  335 
 336 
Pooling of samples is advantageous when biomonitoring is not used to predict specific health 337 
endpoints, but rather to monitor exposure over time, where the individual can be engaged in 338 
behaviours to reduce or eliminate exposures to potentially hazardous chemicals. For example, 339 
the health effects of bisphenol A are not completely understood, despite the large number of 340 
animal studies, and well-characterized exposure in multiple human populations. Even though 341 
the average urinary concentrations correspond to exposure levels well below the reference 342 
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dose set by the European Food Safety Authority [38] there has been widespread community 343 
concern, particularly regarding plastic baby bottles, resulting in the ban or voluntary phase-344 
out of selected bisphenol A-containing products in some countries (e.g. Canada, European 345 
Union and some parts of US; and Australia and New Zealand, respectively). In this instance 346 
the public knowledge gained from large-scale biomonitoring studies motivated community 347 
action that prompted manufacturers to alter their products so consumers could choose to 348 
reduce their exposure.  349 
 350 
The use of population-based biomonitoring data, whether from pooled or individual samples, 351 
for risk assessment or public health applications raises fewer ethical objections than when 352 
the same data are attributable to an individual [34]. For example, the US Centers for Disease 353 
Control and Prevention conducts one of the largest biomonitoring studies worldwide 354 
(NHANES), whereby thousands of individual specimens from the general population are 355 
analysed for a suite of environmental chemicals. The Center does not report individual 356 
results – instead results are reported as geometric means with percentile distributions, whilst 357 
care is taken to emphasise that the presence of the chemical does not necessarily imply harm 358 
has occurred. These descriptive statistics can convey useful information about the higher 359 
distribution and range of levels in the population [39]. The same reasoning can be applied to 360 
pooled specimens, since the result from a pooled specimen cannot be attributed to any one 361 
individual making up that pool. However, when reporting results at the population level, care 362 
needs to be taken to avoid stigmatizing a particular ethnic, geographical or professional 363 
community [34]. 364 
 365 
Targeted Pooling Approaches 366 
Purposive sampling and pooling strategy 367 
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Devers and Frankel [40] discuss the use of ‘purposive’ sampling during qualitative research, 368 
whereby specific individuals, groups, organisations or behaviours are targeted to provide the 369 
greatest insight into the research question. Pooling strategy can be viewed in a similar light, 370 
where the pooling criteria can be extended beyond age and sex to include variables such as 371 
geographic location, socioeconomic status, industry groups etc. Cross-sectional studies with a 372 
large number of individual specimens and observed patterns in analyte concentrations, such 373 
as NHANES [41, 42] can be used to generate hypotheses for future studies, such as the 374 
association between body burden and disease.  375 
 376 
If specific health parameters are available, there is the opportunity to pool samples by 377 
disease, where a set of health endpoints are used as criterion to group samples and this can be 378 
applied to novel research questions. For instance, Thompson et al [43] pooled serum samples 379 
by age, sex, and disease state to investigate potential sex differences in elimination pathways 380 
of various perfluorinated compounds. Females typically have lower levels of these 381 
compounds than males, and it has been suggested that menstruation acts as an additional 382 
elimination pathway. To investigate this samples from adults with regular blood loss (patients 383 
undergoing regular drawing of blood to treat conditions such as haemochromatosis and 384 
polycythaemia) were compared to subjects with no regular blood loss (patients not 385 
undergoing regular treatment). Study designs such as this can be used to target a specific 386 
subpopulation (e.g. disease cases compared to controls) to explore exposure-outcome 387 
relationships and associations.  388 
 389 
Pooling for ‘top-down’ exposomics studies 390 
The science of identifying the particular chemical exposures that lead to a biological response 391 
is called 'exposomics' [44]. Exposomics studies have traditionally followed a 'bottom-up' 392 
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approach in which chemical exposures are characterised based on monitoring data, and 393 
compared to effect levels determined in toxicology studies to demonstrate the likely cause-394 
effect chain that leads to biological responses observed in a population. Pooled biomonitoring 395 
samples have considerable potential to be utilised in the alternative 'top-down' exposomics 396 
study design, where samples are pooled by disease or health parameter, and screened for a 397 
suite of chemicals to identify statistical correlations between exposures and health 398 
parameters. 399 
 400 
Extrapolation from other studies 401 
As mentioned, one of the drawbacks of using pooled samples for biomonitoring is the lack of 402 
information about the variability of exposures within a population. As discussed above, the 403 
analysis of multiple pools may allow estimation of population variation, albeit with 404 
considerable uncertainty [18]. Other approaches can also be explored, based on empirical 405 
examination of comparable datasets i.e. to use the variance from other large scale population 406 
studies where individual results are available, and apply these values to pooled samples in a 407 
separate study. For example, the distribution of analyte concentrations for the US population 408 
as a whole, or for specific subpopulations, can be extrapolated from publicly available 409 
NHANES datasets to estimate the likely degree of variation in other populations [45] (see 410 
examples below). This is particularly true if the factors that lead to population variation in the 411 
US population are likely to be applicable to the second study population for which only 412 
pooled data are available. Such factors might include population variation in intrinsic 413 
elimination kinetics for persistent compounds or variation in dietary patterns leading to 414 
similar distributions of intake of trace dietary contaminants.  415 
 416 
Example 1 417 
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Aylward et al [45] use age-specific data on dioxin-like congeners in serum for the US 418 
population to estimate reference values for the Australian population, based on measurements 419 
in pooled serum samples from an earlier study [46]. The ratio 95th percentile to the arithmetic 420 
mean in each age group of interest was calculated from the US NHANES dataset and applied 421 
to the Australian pooled data to estimate a plausible 95th percentile for the Australian 422 
population. The estimates can be used to: (1) provide information on the variability of dioxin-423 
like congener concentrations in the Australian population, which could not be obtained using 424 
pooled samples; (2) provide an estimate of the range within the population; and (3) identify 425 
samples (individual or pooled) that exceed the upper reference value, which may indicate 426 
elevated exposure.  427 
 428 
Example 2 429 
The use of TCDD as a marker for exposure to Agent Orange in Australian veterans [47] was 430 
assessed by comparing the ratio of two reference congeners (2,3,4,7,8-431 
pentachlorodibenzofuran and 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin) in individual veteran 432 
specimens to pooled samples from the general Australian population [25] and the NHANES 433 
2003-2004 [48] dataset. The distribution of ratios in the Australian veterans was similar to the 434 
distribution in the NHANES dataset, and the mean ratios were similar to both the NHANES 435 
and Australian general population datasets. Upper-bound background levels were estimated 436 
using the method described above and the authors concluded that there was no elevation of 437 
TCDD in Australian veterans compared to the general Australian population. 438 
 439 
Specimen banking 440 
The benefits of environmental specimen banking are well documented [5, 49, 50]. Where 441 
cost, storage space and sample volume are not limiting factors it can be advantageous to store 442 
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individual specimens to allow flexibility in study design to answer unforseen research 443 
questions. However, these factors are often significant impediments to the creation of large, 444 
comprehensive specimen banks. Wise and Koster [51] discussed the feasibility of using 445 
composite tissue samples when there is either insufficient sample available, or when the goal 446 
of the research is to provide information about a specific population, rather than a limited 447 
number of individuals. For example, as part of the United States National Status and Trends 448 
Marine Monitoring Program, composite tissue samples from 50 to 200 fish from a particular 449 
site were pooled and archived [51]. This was sufficient because the goal of the program was 450 
to quantify long-term trends in contaminant concentrations in marine environments, and the 451 
interest was in the contaminant status of the area, not the contaminant status of the individual 452 
fish.   453 
 454 
The same reasoning can be applied to pooled samples of human tissues and fluids. Pooled 455 
samples can alleviate some of the space and financial pressures placed on specimen banks, 456 
because a smaller number of samples can be stored, whilst still being representative of the 457 
larger population. Further, pooling increases the total sample volume and this can be 458 
important when there is a need for multiple aliquots of the same sample for different analyses 459 
over an extended period of time, e.g. analysis of new and emerging chemicals, or for the 460 
analysis of older known toxicants as improved analytical methodologies become available.  461 
 462 
Summary and Conclusions 463 
Biomonitoring studies both with and without a pooling strategy can be used for a variety of 464 
purposes [52], including:  465 
1. To monitor levels of exposure, and identify exposure trends. This can include 466 
investigating variation in exposure and distribution in the general population [21]; 467 
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monitoring exposures cross-sectionally and longitudinally; monitoring temporal 468 
variability (i.e. identifying time trends in exposure); and establishing age distribution 469 
patterns. 470 
2. To assist in policy-making and public health planning. Biomonitoring data can inform 471 
chemical risk assessment and management, and this data can be used to evaluate the 472 
effectiveness of an intervention strategy or regulation, to leverage government 473 
funding, industry action, or legal action; for improved product safety; and to identify 474 
opportunities for exposure reduction. 475 
3. To identify susceptible populations, assess potential risk associated with specific sites 476 
or populations, and record the extent of a community-specific exposure. For example, 477 
to provide a targeted assessment of population exposures in suspected environmental 478 
‘hotspots’ or in the investigation of clusters of disease that may be related to 479 
environmental exposure. 480 
4. To identify exposure sources, the link between exposure and behaviour (e.g. diet), and 481 
the relationship between exposure and disease, with the goal of understanding human 482 
toxicity and metabolism. 483 
5. To identify chemical exposures that may exceed known toxicity benchmarks [39, 53], 484 
and to use the data generated in combination with human reference values and 485 
physiologically-based pharmacokinetic information to model the relationship between 486 
a biomonitoring concentration and existing health-based criteria, such as references 487 
doses or tolerable daily intakes [34].  488 
6. To improve medical diagnoses and treatment, and to assist in interpreting clinical 489 
problems in cases where specific clinical data describing overt effects of chemical 490 
poisoning are available (for example, acute pesticide poisoning [54]). 491 
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7. To detect emerging exposures that may be unexpected or not specifically targeted for 492 
investigation [3, 4, 33, 34, 55]. 493 
 494 
These biomonitoring goals (goals 1-7) are traditionally achieved using individual specimens; 495 
however, pooled samples can be used with some additional benefits. The relatively low 496 
resource requirements and cost-effectiveness of studies using pooled samples makes them 497 
ideal for screening experiments, hypothesis-generating and pilot studies (goal 7).   498 
 499 
Pooled sampling strategies lend themselves in particular to investigations of broad exposure 500 
trends within a population, such as temporal or age trends of POPs in the general population 501 
(goal 1). In these cases, the pool mean is sufficient to monitor exposures over time, 502 
particularly if multiple pools are available per strata, which then gives some indication of the 503 
variability of exposures within the population. Or if each pool contains a large number of 504 
individual samples, a more reliable estimate of the true mean of the broader population can be 505 
made. The type of pooling strategy employed will determine the type on information 506 
available to meet different goals. For instance, if samples are pooled by demographics e.g. 507 
age, geographic location or ethnicity, and results from a particular strata are elevated relative 508 
to the others, this may indicate a ‘susceptible population’ (goal 3). These results can be used 509 
in the same way as results from individual specimens to inform public policy (goal 2).  510 
 511 
The application of pooled samples for identifying exposure sources (goal 4) is limited to the 512 
nature of the pooling strategy. At most, pooled samples may provide some insight into 513 
relative levels of exposure in different locations or communities, but the source of exposure 514 
within that specific population would need to be determined using other methods. Goals 5 515 
and 6 cannot be met due to the nature of pooled samples i.e. no individual data available. 516 
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 517 
Biomonitoring is an extremely valuable tool; however, it is resource-intensive, particularly 518 
with respect to analytical capability and cost. Pooling allows a large number of individuals 519 
from the population to be sampled at reduced analytical costs, and can be useful in 520 
overcoming space and financial restrictions associated with specimen-banking. Pooling 521 
approaches are most obviously supportive of efforts designed to examine broad trends in 522 
chemical exposure over time in the population, or to evaluate patterns of exposure level with 523 
demographic variables such as age and sex. However, a range of innovative approaches 524 
including pooling by factors in addition to age and sex (geographic location, socioeconomic 525 
status, disease state etc.) can expand the possible applications of pooled samples. Pooled 526 
samples have been an under-utilised resource due to the perception that only limited 527 
statistical information is generated, however the careful selection of pooling criteria and 528 
extrapolation from existing datasets can provide proxy information that may be used to 529 
achieve traditional biomonitoring goals.   530 
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Tables 
Table 1: Summary of the considerations for using pooled samples versus individual samples 
in human biomonitoring studies 
 
Figures 
Figure 1 – The already-reported or estimated number of analytes included in the NHANES 
biomonitoring program by two year cycle (columns).  The pie chart shows the percentage of 
chemicals from the 2003-2004 NHANES [48] survey cycle  with a) toxicity values derived 
directly from biomonitoring-based epidemiological studies (~2%); b) assessment values 
derived from risk assessments such as Biomonitoring Equivalents (BEs) or related 
assessment values (such as Human Biomonitoring-I values from the German Human 
Biomonitoring Commission or Biological Exposure Indices (BEIs) established by the 
American Conference of Governmental Industrial Hygienists (reviewed in Angerer et al 2011 
[15]); or c) analytes with no available assessment values. * Estimated total number of 
analytes to be reported. 
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Table 1: Summary of the considerations for using pooled samples versus individual samples 
in human biomonitoring studies 
Consider
ations 
Pooled samples Individual samples 
Statistics  Can only measure arithmetic mean 
 No information about population 
variance 
 Additional statistical descriptors 
can be produced where a 
comparable dataset using individual 
specimens is available 
 Samples may require normalisation 
before pooling 
 Broad statistics available 
E.g. geometric mean, median, 95th 
percentile etc. 
 Data can be interpreted with or 
without normalisation 
E.g. creatinine corrected versus 
volume-based concentration 
Resource
s  
 
 Time saving 
 Reduced analytical costs 
 Participant recruitment may not be 
necessary  
E.g. if using specimens from 
another cohort 
 Conserve space in sample banks 
 Time and resource-intensive 
 Participants must be recruited 
 Challenges associated with 
selection bias in recruitment 
 Relatively high cost 
Analytica
l 
 Larger sample volumes may allow 
higher enrichment factors and/or 
lower method LODs 
 May require large specimen 
volume to reach detection limits 
This may be challenging in certain 
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 Can utilise low sample volumes to 
create a pool that might otherwise 
have been precluded from analysis 
E.g. cord blood 
circumstances e.g. urine from non-
toilet trained children or serum 
from children 
Ethics  May not require participant consent 
E.g. if individual samples are de-
identified before pooling 
 Results do not need to be 
communicated to participants 
 
 Consent required for collection and 
analysis 
 Results must be made available to 
participants, and may require 
strategies for interpretation in a 
health-based context 
 
 
